# A First-in-Patient Clinical Trial of KINE-101 in Patients With Corticosteroid-Refractory CIDP

> **NCT07343310** · PHASE1 · COMPLETED · sponsor: **Kine Sciences Co., Ltd.** · enrollment: 9 (actual)

## Conditions studied

- CIDP - Chronic Inflammatory Demyelinating Polyneuropathy

## Interventions

- **DRUG:** KINE-101

## Key facts

- **NCT ID:** NCT07343310
- **Lead sponsor:** Kine Sciences Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-27
- **Primary completion:** 2025-04-14
- **Final completion:** 2025-04-14
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07343310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07343310, "A First-in-Patient Clinical Trial of KINE-101 in Patients With Corticosteroid-Refractory CIDP". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07343310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*